KRAS and skin cancer: Few studies reported that MAPK4 levels are elevated in lung adenomas of oncogenic K-Ras transgenic mice, and silent mutations or single amino acid substitutions in MAPK4 have been detected in lung and skin cancer tissues43, 44.